Thermo Fisher Scientific (NYSE: TMO) reported Q2 EPS of $1.84, $0.06 better than the analyst estimate of $1.78. Revenue for the quarter came in at $4.27 billion versus the consensus estimate of $4.17 billion.

Thermo Fisher Scientific sees FY2015 EPS of $7.28-$7.41, versus prior guidance of $7.25-$7.40 and the consensus of $7.35. Now sees revenue of $16.72 - $16.86 billion, from $16.67 - $16.83 billion and the consensus of $16.75 billion.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.